September 25, 2016 2:25 AM ET

Biotechnology

Company Overview of FermaVir Pharmaceuticals, L.L.C.

Company Overview

FermaVir Pharmaceuticals, L.L.C. researches, develops, and manufactures biotechnology antiviral drugs and solutions for the treatment of shingles, Cytomegalovirus (CMV) infection, and other infections. It holds licensed patents for a series of compounds for the treatment of viral diseases in the United States. It has patents for compounds for the treatment of varicella zoster virus (VZV), the causative agent for shingles and chickenpox, as well as human cytomegalovirus, which includes the viruses that cause chicken pox, mononucleosis, herpes labialis, and genitalis. The company is conducting preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. In addi...

420 Lexington Avenue

Suite 445

New York, NY 10170

United States

1 Employees

Phone:

212-413-0802

Fax:

212-375-2630

Key Executives for FermaVir Pharmaceuticals, L.L.C.

Founder and Director
Age: 74
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact FermaVir Pharmaceuticals, L.L.C., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.